Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Secreted Lysosome |
Domain |
PF03227 Gamma interferon inducible lysosomal thiol reductase (GILT) |
Function |
Lysosomal thiol reductase that can reduce protein disulfide bonds. May facilitate the complete unfolding of proteins destined for lysosomal degradation. Plays an important role in antigen processing. Facilitates the generation of MHC class II-restricted epitodes from disulfide bond-containing antigen by the endocytic reduction of disulfide bonds (By similarity). Facilitates also MHC class I-restricted recognition of exogenous antigens containing disulfide bonds by CD8+ T-cells or crosspresentation (By similarity). |
Biological Process |
GO:0002474 antigen processing and presentation of peptide antigen via MHC class I GO:0002478 antigen processing and presentation of exogenous peptide antigen GO:0002495 antigen processing and presentation of peptide antigen via MHC class II GO:0002504 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II GO:0019882 antigen processing and presentation GO:0019884 antigen processing and presentation of exogenous antigen GO:0019886 antigen processing and presentation of exogenous peptide antigen via MHC class II GO:0031647 regulation of protein stability GO:0034341 response to interferon-gamma GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I GO:0048002 antigen processing and presentation of peptide antigen GO:0048144 fibroblast proliferation GO:0048145 regulation of fibroblast proliferation GO:0048147 negative regulation of fibroblast proliferation GO:0050821 protein stabilization GO:0060333 interferon-gamma-mediated signaling pathway GO:0071346 cellular response to interferon-gamma |
Molecular Function |
GO:0016667 oxidoreductase activity, acting on a sulfur group of donors |
Cellular Component |
GO:0005775 vacuolar lumen GO:0043202 lysosomal lumen |
KEGG |
hsa04612 Antigen processing and presentation |
Reactome |
R-HSA-1280218: Adaptive Immune System R-HSA-1280215: Cytokine Signaling in Immune system R-HSA-168256: Immune System R-HSA-913531: Interferon Signaling R-HSA-877300: Interferon gamma signaling R-HSA-2132295: MHC class II antigen presentation |
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between IFI30 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between IFI30 and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of IFI30 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of IFI30 in various data sets.
|
Points in the above scatter plot represent the mutation difference of IFI30 in various data sets.
|
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of IFI30. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of IFI30. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by IFI30. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of IFI30. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of IFI30 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between IFI30 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | IFI30 |
Name | interferon, gamma-inducible protein 30 |
Aliases | IFI-30; GILT; IP30; MGC32056; IP-30; gamma-interferon-inducible lysosomal thiol reductase; interferon gamma- ...... |
Chromosomal Location | 19p13.1 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting IFI30 collected from DrugBank database. |
There is no record. |